Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Jun 23, 2021 11:00pm
74 Views
Post# 33439639

RE:RE:AD reading

RE:RE:AD readingNo problem - I can help you better understand LookingforClues if you are struggling with this concept. 

Just ask for help when you need it.  We won't bite.

Look at it this way ... if the brain cells have/produce enough H2S, everything seems to function well.  If cells are H2S defficient we end up with these tangles that affect the nerves from firing properly.  Therefore, we end up with less than ideal brain activity.

Good thing we know a company that is very interested in using their H2S technology for a variety of inflammation-related problem.

See ... better to ask for clarification when you're stumped rather than to critisize ... right ?

: )
<< Previous
Bullboard Posts
Next >>